IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,748,728 | +288.5% | 126,736 | +251.4% | 0.00% | +200.0% |
| Q2 2023 | $1,479,907 | +16.7% | 36,069 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $1,268,359 | -5.2% | 35,489 | +0.2% | 0.00% | 0.0% |
| Q4 2022 | $1,338,134 | -23.0% | 35,429 | -9.8% | 0.00% | 0.0% |
| Q3 2022 | $1,737,000 | +16.3% | 39,264 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $1,494,000 | -55.6% | 40,365 | -55.6% | 0.00% | -50.0% |
| Q1 2022 | $3,366,000 | +21.2% | 90,871 | -0.5% | 0.00% | +100.0% |
| Q4 2021 | $2,778,000 | -19.1% | 91,292 | -10.9% | 0.00% | -50.0% |
| Q3 2021 | $3,435,000 | -10.0% | 102,422 | +7.0% | 0.00% | 0.0% |
| Q2 2021 | $3,818,000 | +3.2% | 95,720 | +16.3% | 0.00% | 0.0% |
| Q1 2021 | $3,701,000 | +13.2% | 82,320 | +42.3% | 0.00% | 0.0% |
| Q4 2020 | $3,270,000 | +24.9% | 57,831 | +4.8% | 0.00% | 0.0% |
| Q3 2020 | $2,618,000 | -17.6% | 55,175 | +2.4% | 0.00% | -33.3% |
| Q2 2020 | $3,177,000 | +20.8% | 53,889 | -3.1% | 0.00% | 0.0% |
| Q1 2020 | $2,629,000 | -21.8% | 55,610 | -0.1% | 0.00% | -25.0% |
| Q4 2019 | $3,361,000 | -2.2% | 55,642 | -3.0% | 0.00% | 0.0% |
| Q3 2019 | $3,438,000 | -10.3% | 57,390 | -3.7% | 0.00% | -20.0% |
| Q2 2019 | $3,831,000 | -10.3% | 59,601 | +13.3% | 0.01% | -16.7% |
| Q1 2019 | $4,271,000 | +28.7% | 52,615 | -14.3% | 0.01% | +20.0% |
| Q4 2018 | $3,318,000 | +107.4% | 61,367 | +59.8% | 0.01% | +25.0% |
| Q2 2018 | $1,600,000 | -8.3% | 38,402 | -3.0% | 0.00% | -20.0% |
| Q1 2018 | $1,745,000 | -32.8% | 39,588 | -23.3% | 0.01% | -16.7% |
| Q4 2017 | $2,596,000 | +0.2% | 51,605 | +1.0% | 0.01% | 0.0% |
| Q3 2017 | $2,590,000 | +11.9% | 51,094 | +12.3% | 0.01% | 0.0% |
| Q2 2017 | $2,314,000 | +28.8% | 45,500 | +1.9% | 0.01% | 0.0% |
| Q1 2017 | $1,796,000 | -13.4% | 44,671 | +3.0% | 0.01% | -25.0% |
| Q4 2016 | $2,074,000 | +55.4% | 43,376 | +19.1% | 0.01% | +60.0% |
| Q3 2016 | $1,335,000 | +5.0% | 36,426 | -33.3% | 0.01% | 0.0% |
| Q2 2016 | $1,272,000 | -50.4% | 54,617 | -13.8% | 0.01% | -54.5% |
| Q1 2016 | $2,566,000 | -33.4% | 63,362 | +1.9% | 0.01% | -35.3% |
| Q4 2015 | $3,850,000 | – | 62,163 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |